Fig. 3 | Scientific Reports

Fig. 3

From: Cudratricusxanthone A exhibits antitumor activity and enhances chemosensitivity to cisplatin against NSCLC via targeting EGFR

Fig. 3

Regulation of CTXA on cell cycle distribution in A549 cells. (A) Cells were treated with various doses of CTXA (3, 6 or 9 µM) for 24 h. The cell cycle distribution (G0/G1, S and G2/M) was detected by flow cytomery and analyzed by FlowJo software. (B) Quantification of cell proportions in each phase of the cell cycle were analyzed. (C) Expression levels of Cyclin D1 and CDK4 were examined by Western blot assay. (D,E) Quantification of CyclinD1 and CDK4 expression levels was analyzed. **p < 0.01, ***p < 0.001 versus the control.

Back to article page